Global Contraceptive Drugs Market

Contraceptive Drugs Market Size, Share, Growth Analysis, By Product(Oral contraceptive pills, Injectable contraceptives, Topical contraceptives), By Distribution Channel(Retail pharmacy, Hospital pharmacy, Clinics, Online channel), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2122 | Region: Global | Published Date: July, 2024
Pages: 242 | Tables: 65 | Figures: 77

Contraceptive Drugs Market Competitive Landscape

Global contraceptive drugs market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global contraceptive drugs market.

Contraceptive Drugs Market Top Player's Company Profiles

  • Pfizer Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Allergan plc
  • Mithra Pharmaceuticals SA
  • Afaxys, Inc.
  • Reckitt Benckiser Group plc
  • CooperSurgical, Inc.
  • Agile Therapeutics, Inc.
  • Novartis International AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck KGaA
  • HLL Lifecare Limited
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • The Female Health Company
  • Okamoto Industries, Inc.

Contraceptive Drugs Market Recent Developments

  • In May 2022, NetVation DL Medicine announced research collaboration with Pfizer Inc. NetVation DL Medicine ("DL Medicine"), a privately held biotechnology business based in Chengdu, China that is focused on the discovery and development of innovative drug concepts, has established two-year research collaboration with Pfizer Inc.
  • In March 2022, Agile Therapeutics collaborated with award-winning director Maya Albanese on the first Twirl advertisement, Gen Z. Agile Therapeutics, Inc., a growing women's healthcare company, announced the release of its first consumer advertisement, Twirla Weekly Birth Control Patch Awareness.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Contraceptive Drugs Market size was valued at USD 29996.6 million in 2022 and is poised to grow from USD 31946.38 million in 2023 to USD 52871.12 million by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).

Global contraceptive drugs market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global contraceptive drugs market. 'Pfizer Inc.', 'Bayer AG', 'Merck & Co., Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Allergan plc', 'Mithra Pharmaceuticals SA', 'Afaxys, Inc.', 'Reckitt Benckiser Group plc', 'CooperSurgical, Inc.', 'Agile Therapeutics, Inc.', 'Novartis International AG', 'GlaxoSmithKline plc', 'Johnson & Johnson', 'Merck KGaA', 'HLL Lifecare Limited', 'Church & Dwight Co., Inc.', 'Mayer Laboratories, Inc.', 'The Female Health Company', 'Okamoto Industries, Inc.', 'In May 2022, NetVation DL Medicine announced research collaboration with Pfizer Inc. NetVation DL Medicine ("DL Medicine"), a privately held biotechnology business based in Chengdu, China that is focused on the discovery and development of innovative drug concepts, has established two-year research collaboration with Pfizer Inc.', 'In March 2022, Agile Therapeutics collaborated with award-winning director Maya Albanese on the first Twirl advertisement, Gen Z. Agile Therapeutics, Inc., a growing women's healthcare company, announced the release of its first consumer advertisement, Twirla Weekly Birth Control Patch Awareness.'

Preventing Unwanted Pregnancies

Technological advancement is an ongoing trend gaining popularity in the contraceptive drugs market. Digital contraception is the latest trend in the market. Digital contraception is a way to track periods online to know which days are at risk for pregnancy. In March 2021, Berlin-based femtech company Clu received FDA approval to market Clu Birth Control, an all-digital contraceptive based on period monitoring data. The contraceptive function can combine a user's menstrual cycle data with Clue's prediction algorithm to identify when there is a high or low risk for pregnancy. Users can then adjust their habits to their risk tolerance. Clue recommends that users refrain from intercourse altogether or use another form of contraception, such as condoms, on high-risk days.

On the basis of region, global contraceptive drugs market is divided into North America, Europe, Asia Pacific and MEA. North America dominated global market in 2022, due to the high incidence of abortion, rising population of women within the age group of 15-44 years, and high patient awareness levels in this region. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives in teenagers. The U.S. is dominating the contraceptive drugs market in North America. The increased awareness of contraceptive pills among patients is driving the growth of the market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Contraceptive Drugs Market

Report ID: SQMIG35I2122

$5,300
BUY NOW GET FREE SAMPLE